Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hadjiargyrou

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Behavioural Brain Research|August 28, 2018
Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effectsEmily Carias, Dennis Fricke, Abisha Vijayashanthar, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|February 17, 2025
Clinicopathological correlations and prognostic insights in osteosarcoma: a retrospective analysisŞtefan Adrian Niculescu, Alexandru Florian Grecu, Alex Emilian Stepan, et al.
Bone|December 3, 2022
Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal developmentAlexander A Chirokikh, Sardar M Z Uddin, Nadine Areikat, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Indole-Based PDE5 Inhibitors: Synthesis and Pharmacological EvaluationShin-Young Park, Dang Pham, Param Shukla, et al.
Pharmacology, Biochemistry, and Behavior|February 3, 2015
A pharmacokinetic model of oral methylphenidate in the rat and effects on behaviorPanayotis K Thanos, Lisa S Robison, Jessica Steier, et al.
Journal of Personalized Medicine|April 28, 2023
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A ReviewDaniela Senior, Rania Ahmed, Eliz Arnavut, et al.
Neurochemical Research|July 11, 2025
Combined Chronic Oral Methylphenidate and Fluoxetine Decreases D2R Levels in the Caudate Putamen and Nucleus AccumbensGeorge Lagamjis, Huy Lu, Nicole M Roeder, et al.
Developmental Psychobiology|August 29, 2019
Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effectsLeanna Kalinowski, Carly Connor, Rathini Somanesan, et al.
FASEB Bioadvances|December 14, 2023
<i>Mustn1</i> ablation in skeletal muscle results in functional alterationsCharles J Kim, Chanpreet Singh, Marina Kaczmarek, et al.
Bone|April 3, 2012
Chronic exposure to methylphenidate impairs appendicular bone quality in young ratsDavid E Komatsu, Panayotis K Thanos, Michelle N Mary, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Behavioural Brain Research|August 28, 2018
Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effectsEmily Carias, Dennis Fricke, Abisha Vijayashanthar, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|February 17, 2025
Clinicopathological correlations and prognostic insights in osteosarcoma: a retrospective analysisŞtefan Adrian Niculescu, Alexandru Florian Grecu, Alex Emilian Stepan, et al.
Bone|December 3, 2022
Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal developmentAlexander A Chirokikh, Sardar M Z Uddin, Nadine Areikat, et al.
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Indole-Based PDE5 Inhibitors: Synthesis and Pharmacological EvaluationShin-Young Park, Dang Pham, Param Shukla, et al.
Pharmacology, Biochemistry, and Behavior|February 3, 2015
A pharmacokinetic model of oral methylphenidate in the rat and effects on behaviorPanayotis K Thanos, Lisa S Robison, Jessica Steier, et al.
Journal of Personalized Medicine|April 28, 2023
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A ReviewDaniela Senior, Rania Ahmed, Eliz Arnavut, et al.
Neurochemical Research|July 11, 2025
Combined Chronic Oral Methylphenidate and Fluoxetine Decreases D2R Levels in the Caudate Putamen and Nucleus AccumbensGeorge Lagamjis, Huy Lu, Nicole M Roeder, et al.
Developmental Psychobiology|August 29, 2019
Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effectsLeanna Kalinowski, Carly Connor, Rathini Somanesan, et al.
FASEB Bioadvances|December 14, 2023
<i>Mustn1</i> ablation in skeletal muscle results in functional alterationsCharles J Kim, Chanpreet Singh, Marina Kaczmarek, et al.
Bone|April 3, 2012
Chronic exposure to methylphenidate impairs appendicular bone quality in young ratsDavid E Komatsu, Panayotis K Thanos, Michelle N Mary, et al.
Pageof 10